News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,737 Results
Type
Article (13821)
Company Profile (292)
Press Release (244624)
Section
Business (79300)
Career Advice (148)
Deals (13175)
Drug Delivery (31)
Drug Development (50258)
Employer Resources (31)
FDA (5667)
Job Trends (5109)
News (144013)
Policy (10013)
Tag
Academia (901)
Alliances (21439)
Alzheimer's disease (727)
Approvals (5631)
Artificial intelligence (58)
Bankruptcy (97)
Best Places to Work (4452)
Biotechnology (240)
Breast cancer (51)
Cancer (557)
Cardiovascular disease (50)
Career advice (129)
Cell therapy (144)
Clinical research (39550)
Collaboration (198)
Compensation (78)
COVID-19 (998)
C-suite (48)
Cystic fibrosis (61)
Data (591)
Diabetes (60)
Diagnostics (1190)
Earnings (28541)
Events (46412)
Executive appointments (147)
FDA (5902)
Funding (205)
Gene editing (46)
Gene therapy (124)
GLP-1 (286)
Government (1062)
Healthcare (6524)
Infectious disease (1027)
Inflammatory bowel disease (88)
IPO (7164)
Job creations (859)
Job search strategy (125)
Layoffs (181)
Legal (1372)
Lung cancer (100)
Manufacturing (64)
Medical device (2545)
Medtech (2546)
Mergers & acquisitions (6082)
Metabolic disorders (192)
Neuroscience (905)
NextGen Class of 2024 (1993)
Non-profit (841)
Northern California (760)
Obesity (112)
Opinion (89)
Parkinson's disease (54)
Patents (45)
People (24871)
Pharmaceutical (47)
Phase I (13899)
Phase II (18385)
Phase III (11678)
Pipeline (132)
Postmarket research (846)
Preclinical (5864)
Radiopharmaceuticals (203)
Rare diseases (138)
Real estate (1409)
Regulatory (8152)
Research institute (930)
Southern California (702)
Startups (1963)
United States (6416)
Vaccines (152)
Weight loss (69)
Date
Last 7 days (465)
Last 30 days (1635)
Last 365 days (20602)
2024 (17459)
2023 (22415)
2022 (26822)
2021 (27807)
2020 (23357)
2019 (16224)
2018 (11738)
2017 (13748)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Arizona (42)
Asia (16757)
Australia (2818)
California (1723)
Canada (633)
China (133)
Colorado (62)
Connecticut (68)
Europe (36048)
Florida (186)
Georgia (50)
Illinois (109)
Indiana (50)
Kansas (54)
Maryland (253)
Massachusetts (1427)
Michigan (45)
Minnesota (81)
New Jersey (470)
New York (531)
North Carolina (377)
Northern California (760)
Ohio (69)
Pennsylvania (368)
South America (207)
Southern California (702)
Texas (175)
Washington State (192)
258,737 Results for "akcea therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Deals
Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the successful completion of its transaction to acquire 100% ownership of Akcea Therapeutics, Inc. (NASDAQ: AKCA). The combination of Ionis and Akcea accelerates the next phase of Ionis’ gr
October 12, 2020
·
5 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Business
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
Contineum Therapeutics, Inc. (Nasdaq: CTNM) today announced the appointment of Sarah Boyce, President and Chief Executive Officer of Avidity Biosciences, Inc. (Nasdaq: RNA), as an independent member of its Board of Directors.
June 24, 2024
·
5 min read
Layoffs
Relay Therapeutics to Lay Off 10% of Workforce
Relay Therapeutics is cutting its workforce to help streamline its research organization as it looks to complete its first large-scale, pivotal clinical trial.
October 4, 2024
·
1 min read
·
Angela Gabriel
Deals
Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics
Ionis to acquire remaining 24% of common stock of Akcea it does not already own for $18.15 per share in cash
August 31, 2020
·
10 min read
Layoffs
Sage Therapeutics Will Lay Off 33% of Employees, Including Over Half of R&D
As part of a strategic reorganization intended in part to support the ongoing launch of its postpartum depression drug, Sage Therapeutics is cutting more than 165 employees.
October 17, 2024
·
2 min read
·
Angela Gabriel
Drug Development
Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen (AKCEA-ANGPTL3-LRx)
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and its wholly owned subsidiary Akcea Therapeutics, Inc., today announced that Pfizer Inc. (NYSE: PFE) has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in statin-treated patients with elevated non-high-density lipoprotein cholesterol (non-HDL-C) and triglycerides (TGs).
November 3, 2020
·
6 min read
Pharm Country
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Aquestive Therapeutics, Inc. announced that the Aquestive management team will participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism and host investor meetings on July 9, 2024.
June 27, 2024
·
2 min read
1 of 25,874
Next